RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion

被引:32
作者
Rouzer, CA [1 ]
Jacobs, AT
Nirodi, CS
Kingsley, PJ
Morrow, JD
Marnett, LJ
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem & Chem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Ctr Pharmacol & Drug Toxicol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Dept Clin Pharmacol, Nashville, TN 37232 USA
关键词
macrophage; lipopolysaccharide; cyclooxygenase-1; cyclooxygenase-2; arachidonic acid; cytosolic phospholipase A(2);
D O I
10.1194/jlr.M500006-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies of the response of RAW264.7 cells ( RAW) to lipopolysaccharide (LPS) were carried out to determine why these cells do not demonstrate the prostaglandin (PG)dependent autocrine regulation of tumor necrosis factor-alpha (TNF-alpha) secretion observed in primary resident peritoneal macrophages (RPMs). The major cyclooxygenase (COX) product of LPS-stimulated RAW was PGD(2), with lesser amounts of PGE(2). LPS-treated RAW produced PGs more slowly and reached their maximal PG synthetic rate later than did LPS-treated RPMs, as a result of lower constitutive COX-1 expression and a slower rate of COX-2 induction. Cytosolic phospholipase A(2) and levels of free arachidonic acid were similar in RAW and RPMs. In contrast to RPMs, LPS-treated RAW produced high quantities of TNF-alpha, which were not altered in the presence of COX inhibitors. This failure of endogenous PGs to suppress TNF-alpha secretion was explained by the absence of the prostaglandin D-2 receptor and the low levels of PGE(2) produced during the first 2 h of the LPS response. These studies demonstrate that autocrine regulation of TNF-alpha secretion in response to LPS is greatly facilitated by a COX-1-mediated rapid accumulation of PGs as well by a correspondence between the PGs produced and the receptors expressed by the cells.
引用
收藏
页码:1027 / 1037
页数:11
相关论文
共 47 条
[11]   The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs [J].
Greig, GM ;
Francis, DA ;
Falgueyret, JP ;
Ouellet, M ;
Percival, MD ;
Roy, P ;
Bayly, C ;
Mancini, JA ;
ONeill, GP .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :829-838
[12]   Role of Val(509) in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents [J].
Guo, QP ;
Wang, LH ;
Ruan, KH ;
Kulmacz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19134-19139
[13]   DETECTION AND ISOLATION OF AN ENDOPEROXIDE INTERMEDIATE IN PROSTAGLANDIN BIOSYNTHESIS [J].
HAMBERG, M ;
SAMUELSS.B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (03) :899-903
[14]   ISOLATION AND STRUCTURE OF 2 PROSTAGLANDIN ENDOPEROXIDES THAT CAUSE PLATELET-AGGREGATION [J].
HAMBERG, M ;
SVENSSON, J ;
WAKABAYASHI, T ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (02) :345-349
[15]   Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation [J].
Hata, AN ;
Breyer, RM .
PHARMACOLOGY & THERAPEUTICS, 2004, 103 (02) :147-166
[16]   Prostaglandin synthase 2 [J].
Herschman, HR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01) :125-140
[17]   Localization and regulation of cytosolic phospholipase A2 [J].
Hirabayashi, T ;
Shimizu, T .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1488 (1-2) :124-138
[18]   HUMAN CYCLOOXYGENASE-2 CDNA [J].
HLA, T ;
NEILSON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388
[19]  
HUMES JL, 1980, J IMMUNOL, V124, P2110
[20]   Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors [J].
Kalgutkar, AS ;
Crews, BC ;
Rowlinson, SW ;
Marnett, AB ;
Kozak, KR ;
Remmel, RP ;
Marnett, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :925-930